Borchardt; Thomas B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Borchardt; Thomas B..The latest application filed is for "processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof".

Company Profile

5.19.30

Borchardt; Thomas B. - Kenosha WI
Borchardt; Thomas B. - Pleasant Prairie WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20220281882 - Allian; Ayman ; et al.	2022-09-08
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20220267342 - Allian; Ayman ; et al.	2022-08-25
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20220251101 - ALLIAN; Ayman ; et al.	2022-08-11
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20220073530 - ALLIAN; Ayman ; et al.	2022-03-10
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Grant 11,198,697 - Allian , et al. December 14, 2	2021-12-14
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Grant 11,186,584 - Allian , et al. November 30, 2	2021-11-30
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20210363149 - ALLIAN; Ayman ; et al.	2021-11-25
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20210309667 - ALLIAN; Ayman ; et al.	2021-10-07
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof Grant 10,981,923 - Allian , et al. April 20, 2	2021-04-20
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20200385393 - Pangan; Aileen L. ; et al.	2020-12-10
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20200317682 - ALLIAN; Ayman ; et al.	2020-10-08
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20200291040 - ALLIAN; Ayman ; et al.	2020-09-17
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2- ,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20190023714 - ALLIAN; Ayman ; et al.	2019-01-24
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2- ,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20180298016 - Pangan; Aileen L. ; et al.	2018-10-18
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-.alpha.]pyrrolo[2,3-e]-pyrazin-8-yl)-N-- (2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereof Grant 10,017,517 - Borchardt , et al. July 10, 2	2018-07-10
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2- ,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF App 20180162865 - BORCHARDT; Thomas B. ; et al.	2018-06-14
Synthesis Of (2s,5r)-5-ethynyl-1-pyrrolidine-2-carbonitrile App 20160152600 - McDermott; Todd S. ; et al.	2016-06-02
Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl- )glycyl}pyrrolidine-2-carbonitrile Grant 9,260,411 - McDermott , et al. February 16, 2	2016-02-16
Crystalline chemotherapeutic Grant 8,759,538 - Borchardt June 24, 2	2014-06-24
ABT-263 crystalline forms Grant 8,513,243 - Zhang , et al. August 20, 2	2013-08-20
Crystalline chemotherapeutic Grant 8,486,988 - Borchardt July 16, 2	2013-07-16
ABT-263 crystalline forms Grant 8,362,014 - Zhang , et al. January 29, 2	2013-01-29
Abt-263 Crystalline Forms App 20110294811 - Zhang; Geoff G. Z. ; et al.	2011-12-01
Crystalline Chemotherapeutic App 20110196010 - Borchardt; Thomas B.	2011-08-11
Crystalline chemotherapeutic Grant 7,994,208 - Borchardt August 9, 2	2011-08-09
Crystalline chemotherapeutic Grant 7,960,564 - Borchardt , et al. June 14, 2	2011-06-14
Crystalline chemotherapeutic Grant 7,947,843 - Borchardt , et al. May 24, 2	2011-05-24
Abt-263 Crystalline Forms App 20110071151 - Zhang; Geoff G.Z. ; et al.	2011-03-24
Crystalline form 2 of the chemotherapeutic N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea Grant 7,772,404 - Borchardt , et al. August 10, 2	2010-08-10
Eplerenone Drug Substance Having High Phase Purity App 20090149431 - Barton; Kathleen P. ; et al.	2009-06-11
Anti-infective agents Grant 7,538,105 - Hutchinson , et al. May 26, 2	2009-05-26
Crystalline Chemotherapeutic App 20090124815 - Borchardt; Thomas B.	2009-05-14
Crystalline Chemotherapeutic App 20090124816 - Borchardt; Thomas B.	2009-05-14
Crystalline Chemotherapeutic App 20090118344 - Borchardt; Thomas B.	2009-05-07
Anti-Infective Agents App 20080193413 - Hutchinson; Douglas K. ; et al.	2008-08-14
Anti-infective agents Grant 7,378,414 - Hutchinson , et al. May 27, 2	2008-05-27
Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl- )glycyl}pyrrolidine-2-carbonitrile App 20080058528 - McDermott; Todd S. ; et al.	2008-03-06
Eplerenone crystalline form exhibiting enhanced dissolution rate App 20050267302 - Barton, Kathleen P. ; et al.	2005-12-01
Eplerenone drug substance having high phase purity App 20050261261 - Barton, Kathleen P. ; et al.	2005-11-24
Eplerenone crystal form exhibiting enhanced dissolution rate App 20050159594 - Barton, Kathleen P. ; et al.	2005-07-21
Anti-infective agents App 20050107364 - Hutchinson, Douglas K. ; et al.	2005-05-19
Crystalline parecoxib sodium App 20030232871 - Sheikh, Ahmad Y. ; et al.	2003-12-18
Eplerenone drug substance having high phase purity App 20030083493 - Barton, Kathleen P. ; et al.	2003-05-01
Eplerenone crystalline form App 20020045746 - Barton, Kathleen P. ; et al.	2002-04-18
Eplerenone crystalline form exhibiting enhanced dissolution rate App 20020038021 - Barton, Kathleen P. ; et al.	2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.